% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • jfk123_1 jfk123_1 Oct 28, 2013 1:54 PM Flag

    Well we know that Stifel Nicolaus is on the short side

    Hammered home the point about "increased risk", even though did not mention that risk is already more than discounted in shares, and that the phase 2 and the news today actually DERISKS phase 3. But it is a bit like expecting objectivity from AF.

    The point on cash and the additional costs to ramp up a few hundred more subjects is valid. But he underestimates the ability to raise financing from insiders and also the potential for partnership cash injections - which is something that is underway and could be announced at any moment.

0.3430.000(0.00%)Jul 22 4:00 PMEDT